ANALISIS MINIMALISASI BIAYA PENGGUNAAN OBAT ANTIDIABETIK PASIEN RAWAT INAP DIABETES MELITUS DENGAN HIPERTENSI DI RUMAH SAKIT PKU MUHAMMADIYAH GAMPING PERIODE JANUARI-JULI 2024
DOI:
https://doi.org/10.36387/jifi.v8i2.2769Keywords:
Cost Minimazation, Antidiabetic, Diabetes Mellitus, Hypertension, HospitalAbstract
Diabetes mellitus is a chronic disease with increasing prevalence globally. The prevalence of diabetes mellitus in the Special Region of Yogyakarta was 23.3% in 2022 and increased to 64.8% in 2023, with 17,050 sufferers in Sleman Regency. This high prevalence increases the risk of cardiovascular complications and increases the cost of treatment, which adds to the overall economic burden. The purpose of this study was to determine the characteristics of respondents, the profile of antidiabetic drugs, and the minimum cost of antidiabetic therapy for inpatients with diabetes mellitus and hypertension at PKU Muhammadiyah Gamping Hospital. The study was conducted using a descriptive design with retrospective secondary data collection from the medical records section for the period January-July 2024. Cost data were analyzed using the Cost Minimization Analysis (CMA) method. The results showed that the majority of patients were women aged 55–65 years with BPJS coverage. The most common single therapy was insulin novorapid flexpen (8 patients), while the most common combination therapy was metformin and novorapid flexpen (4 patients). The minimum therapy cost is Rp. 3,286,700 with the combination therapy group of insulin lantus and novorapid.
References
1. R. I. Dyah, D. Wahyono, and T. M. Andayani, “Analisis Biaya Terapi Pasien Diabetes Melitus Rawat Inap,” J. Manaj. dan Pelayanan Farm., vol. 4, no. 1, pp. 55–62, 2014.
2. Dinkes DIY, “Buku Data Kesehatan 2023,” Buku Data 2023, p. 41, 2024, [Online]. Available: https://dinkes.jogjaprov.go.id/litkes/download/342
3. Y. Wu, Y. Ding, Y. Tanaka, and W. Zhang, “Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention,” Int. J. Med. Sci., vol. 11, no. 11, pp. 1185–1200, 2014, doi: 10.7150/ijms.10001.
4. Kemenkes, “Lindungi Keluarga Dari Diabetes,” p2ptm.kemkes.go.id. Accessed: Aug. 08, 2024. [Online]. Available: https://p2ptm.kemkes.go.id/post/lindungi-keluarga-dari-diabetes
5. P. Wulandari, Arifianto, and D. Sekarningrum, “Pengaruh Rendam Kaki Menggunakan Air Hangat Dengan Campuran Garam Dan Serai Terhadap Penurunan Tekanan Darah Pada Penderita Hipertensi Di Wilayah Podorejo Rw 8 Ngaliyan,” J. Keperawatan, vol. 7, no. 1, pp. 43–47, 2016, doi: 10.22219/jk.v7i1.3918.
6. E. L. Johnson et al., “Standards of medical care in diabetes - 2021 abridged for primary care providers,” Clin. Diabetes, vol. 39, no. 1, pp. 14–43, 2021, doi: 10.2337/cd21-as01.
7. F. A. Fatimah, S. T. Mualifah, L. Hidayati, and A. F. Nilansari, “Cost Consequence Analysis of Antidiabetic Therapy in Covid-19 Hospitalized Patients with Diabetes Mellitus at Panembahan Senopati Hospital Yogyakarta,” vol. 21, no. 1, pp. 41–50, 2024, doi: 10.23917/pharmacon.v21i1.4509.
8. Badan Pusat Statistik, “Sensus Penduduk Tahun 2020,” Badan Pusat Statistik Indonesia. Accessed: Sep. 09, 2024. [Online]. Available: https://sensus.bps.go.id/main/index/sp2020
9. Depkes RI, Klasifikasi Umur Menurut Kategori. Jakarta: Ditjen Yankes, 2009.
10. E. Nurhidayah, “Analisis Minimalisasi Biaya Terapi Antidiabetes pada Pasien Rawat Inap di RSUD Panembahan Senopati Bantul Periode Januari-Juli 2023,” Skripsi Univ. Nahdlatul Ulama Yogyakarta, 2024.
11. M. Akbar, M. Ardana, and H. Kuncoro, “Analisis Minimalisasi Biaya (Cost-Minimization Analysis) Pasien Gastritis Rawat Inap di RSUD Abdul Wahab Sjahranie Samarinda,” Mulawarman Pharm. Conf., pp. 14–21, 2018.
12. A. Harjanto, “Analisis Efektivitas Biaya Antidiabetik Oral Pada Penderita Diabetes Melitus Tipe 2 Rawat Inap Peserta BPJS Di RSUD Sukoharjo Tahun 2016,” Skripsi Universitas Muhammadiyah Surakarta, 2017.
13. D. Prasetyani and Sodikin, “Analisis Faktor Yang Mempengaruhi Kejadian Diabetes Melitus (DM) Tipe 2,” J. Kesehat. Al Irsyad, vol. 2, no. 2, pp. 1–9, 2017.
14. Rofikoh, S. Handayani, and I. Suraya, “Determinan Kejadian Diabetes Melitus Tipe 2 di Posbindu Mawar Kuning Gambir The Determinant of Diabetes Mellitus Type 2 in Posbindu Mawar Kuning Gambir,” Arkesmas, vol. 5, no. 1, pp. 42–48, 2020.
15. M. . Derek, J. . Rottie, and Vandri, “Hubungan Tingkat Stress dengan Kadar Gula Darah pada Penderita Diabetes Melitus Tipe 2 di Rumah Sakit Pancaran Kasih GMIM Manado,” J. Keperawatan, vol. 5, no. 1, 2017.
16. L. Adam and M. B. Tomayahu, “Tingkat Stres Dengan Kadar Gula Darah Pada Pasien Diabetes Melitus,” Jambura Heal. Sport J., vol. 1, no. 1, pp. 1–5, 2019, doi: 10.37311/jhsj.v1i1.2047.
17. S. . Malairu and J. Pitoyo, “Perbedaan Kualitas Hidup Lansia yang Aktif Mengikuti Posyandu Lansia dengan yang Tidak Aktif Mengikuti Posyandu Lansia di Kelurahan,” Prof. Heal. J., vol. 1, no. 2, pp. 65–72, 2020.
18. I. K. Lubis and S. Susilawati, “Analisis length of stay (LOS) berdasarkan faktor prediktor pada pasien DM tipe II di RS PKU Muhammadiyah Yogyakarta,” J. Kesehat. Vokasional, 2017, [Online]. Available: https://journal.ugm.ac.id/jkesvo/article/view/30330
19. Rummiati and M. P. Kusumo, “Service Quality Of Patients With BPJS PBI and BPJS Non PBI In Local Hospitals,” J. Heal. Sci. Community, vol. 2, no. 3, pp. 1–20, 2018.
20. S. Mastuti, F. Nurul, and K. Kusumastuti, “Gambaran Tingkat Kepuasan Pelayanan Pada Pasien Bpjs Pbi Dan Pasien Bpjs Non Pbi Yang Dirawat Di Kelas Iii Rumah Sakit Pku Muhammadiyah Gombong,” J. Ilm. Kesehat. Keperawatan, vol. 17, no. 2, p. 171, 2021, doi: 10.26753/jikk.v17i2.660.
21. A. N. Sinayu, R. Hasina, and H. S. Harahap, “Pola penggunaan obat anti diabetes mellitus tipe-II pada pasien rawat inap di RSUD Praya tahun 2021,” Sasambo J. Pharm., vol. 5, no. 1, pp. 32–37, 2024, doi: 10.29303/sjp.v5i1.254.
22. M. Djahido, W. I. Wiyono, and D. A. Mpila, “Pola Penggunaan Insulin Pada Pasien Diabetes Melitus Tipe I Di Instalasi Rawat Jalan Rsup Prof. Dr. R. D. Kandou Manado,” Pharmacon, vol. 9, no. 1, p. 82, 2020, doi: 10.35799/pha.9.2020.27413.
23. F. Baroroh, W. Yuliana Solikah, and A. Urfiyya, “Cost Analysis Of Type 2 Diabetes Mellitus In PKU Muhammadiyah Bantul Yogyakarta Hospital,” J. Sci. Pract. Pharm., vol. 16, no. 2, pp. 11–12, 2016.
24. V. Gamayanti, N. L. M. . Ratnasari, and A. Bhargah, “Pola Penggunaan Insulin Pada Pasien Diabetes Melitus Tipe 2 Di Poli Penyakit Dalam RSU Negara Periode Juli-Agustus 2018,” Intisari Sains Medis, vol. 9, no. 3, pp. 68–73, 2018.
25. I. . Wijaya, A. Faturrohmah, A. Yuda, Mufarrihah, T. . Soestanto, and G. Kartika, “Profil Penggunaan Obat Pada Pasien Diabetes Melitus Di Puskesmas Wilayah Surabaya Timur.,” J. Farm. Komunitas, vol. 2, no. 1, pp. 23–28, 2015.
26. N. Norhalimah, R. Agustina, and R. Rusli, “Analisis Biaya Minimal dan Efektivitas Terapi Diabetes Melitus Tipe 2 di RSUD Panglima Sebaya Paser,” Proceeding Mulawarman Pharm. Conf., vol. 7, pp. 63–69, 2018, doi: 10.25026/mpc.v7i1.294.
27. A. . Damayanti, A. Rohendi, and A. . Rahim, “Pengaruh Tingkat Kelas Dan Biaya Terhadap Kualitas Pelayanan Di Rs Mutiara Hati Subang,” J. ARS Univ., vol. 1, no. 2, 2023.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jurnal Insan Farmasi Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
